GE HealthCare Technologies Inc.
GEHC- Exchange
- Nasdaq
- Industry
- X-Ray Apparatus & Tubes & Related Irradiation Apparatus
- SEC CIK
- 0001932393
No open-market purchases or sales by GE HealthCare Technologies Inc. insiders were filed in the last 90 days; 1,222 institutions reported holding it in 13F filings for Q3 2026, worth $26.4B in total; 3 superinvestors hold it, including Harris Associates (Oakmark) and Trian Fund Management.
Holders of 5% or more of GEHC
Holders whose latest Schedule 13D or 13G filing reports 5% or more of GE HealthCare Technologies Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Dodge & Cox | 13G/A | 10.50%47.3M shares | +2.20 ppfrom 8.30% | Aug 13, 20255 filings | Aug 7, 2026 | SEC |
| Vanguard Capital Management LLC | 13G | 7.31%33.4M shares | New | Apr 29, 20261 filing | Apr 29, 2026 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
24 Schedule 13D and 13G filings on GE HealthCare Technologies Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Aug 7, 20261:41 PM ET | Dodge & Cox | 13G/A | 10.50%47.3M shares | +2.20 ppfrom 8.30% | Jul 31, 2026 | SEC |
| Aug 7, 20261:36 PM ET | Dodge & Cox | 13G/A | 8.30%37.9M shares | +1.40 ppfrom 6.90% | Jun 30, 2026 | SEC |
| May 14, 202612:41 PM ET | Dodge & Cox | 13G/A | 6.90%31.3M shares | 0.00 ppfrom 6.90% | Mar 31, 2026 | SEC |
| May 14, 202610:19 AM ET | Capital Research Global Investors | 13G/A | 4.60%21.1M shares | −0.90 ppfrom 5.50%Below 5% | Mar 31, 2026 | SEC |
| Apr 29, 20266:39 PM ET | Vanguard Capital Management LLC | 13G | 7.31%33.4M shares | New | Mar 31, 2026 | SEC |
| Mar 26, 20266:37 PM ET | Vanguard Group Inc | 13G/A | 0.00%0 shares | −11.49 ppfrom 11.49%Below 5% | Mar 13, 2026 | SEC |
| Feb 13, 20261:22 PM ET | Dodge & Cox | 13G/A | 6.90%31.2M shares | +1.80 ppfrom 5.10% | Dec 31, 2025 | SEC |
| Nov 13, 202510:29 AM ET | Capital Research Global Investors | 13G | 5.50%25.0M shares | +0.70 ppfrom 4.80% | Sep 30, 2025 | SEC |
| Aug 13, 20254:35 PM ET | Dodge & Cox | 13G | 5.10%23.6M shares | New | Jun 30, 2025 | SEC |
| Jun 6, 202511:26 AM ET | Capital Research Global Investors | 13G/A | 4.80%22.0M shares | −6.40 ppfrom 11.20%Below 5% | May 30, 2025 | SEC |
| May 13, 202511:32 AM ET | Capital Research Global Investors | 13G/A | 11.20%51.2M shares | – | Mar 31, 2025 | SEC |
| Jan 30, 20259:57 PM ET | Vanguard Group Inc | 13G/A | 11.49%52.5M shares | – | Dec 31, 2024 | SEC |
| Nov 12, 2024 | Capital Research Global Investors | 13G/AOld format | – | – | – | SEC |
| Nov 8, 2024 | BlackRock, Inc. | 13G/AOld format | – | – | – | SEC |
| Oct 22, 2024 | BlackRock, Inc. | 13G/AOld format | – | – | – | SEC |
| Oct 22, 2024 | General Electric Co | 13G/AOld format | – | – | – | SEC |
| Apr 2, 2024 | General Electric Co | 13G/AOld format | – | – | – | SEC |
| Mar 11, 2024 | Vanguard Group Inc | 13G/AOld format | – | – | – | SEC |
| Feb 13, 2024 | Vanguard Group Inc | 13GOld format | – | New | – | SEC |
| Feb 9, 2024 | Capital Research Global Investors | 13G/AOld format | – | – | – | SEC |
| Feb 2, 2024 | General Electric Co | 13G/AOld format | – | – | – | SEC |
| Jan 29, 20243:26 PM ET | BlackRock Inc. | 13GOld format | – | New | – | SEC |
| May 10, 2023 | Capital Research Global Investors | 13GOld format | – | New | – | SEC |
| Feb 10, 2023 | General Electric Co | 13GOld format | – | New | – | SEC |
Form 144: proposed insider sales
15 notices from officers, directors and other affiliates planning to sell GE HealthCare Technologies Inc. shares, newest first.
| Filed (ET) | Seller | Shares to sell | Market value | Planned sale | Broker | Filing |
|---|---|---|---|---|---|---|
| Nov 4, 20264:47 PM ET | James SaccaroFormer officer | 78.3K | $6.73M | Nov 4, 2026 | UBS Financial Services Inc | SEC |
| Nov 24, 20254:24 PM ET | Kenneth StacherskiFormer officer | 4.58K | $353.0K | Nov 24, 2025 | UBS Financial Services Inc | SEC |
| Oct 27, 20254:26 PM ET | Kenneth StacherskiFormer officer | 4.58K | $362.0K | Oct 27, 2025 | UBS Financial Services Inc | SEC |
| Sep 22, 20254:44 PM ET | Kenneth StacherskiFormer officer | 19.5K | $1.45M | Sep 22, 2025 | UBS Financial Services Inc | SEC |
| Sep 12, 20254:47 PM ET | Kenneth StacherskiFormer officer | 11.8K | $905.6K | Sep 12, 2025 | UBS Financial Services Inc | SEC |
| Nov 6, 20245:45 PM ET | Roland RottOfficer | 3.58K | $309.3K | Nov 6, 2024 | UBS Financial Services Inc | SEC |
| Nov 5, 20245:22 PM ET | Philip RackliffeOfficer | 900 | $78.9K | Nov 5, 2024 | UBS Financial Services Inc | SEC |
| Aug 14, 20245:57 PM ET | Kenneth StacherskiOfficer | 19.0K | $1.57M | Aug 14, 2024 | UBS Financial Services Inc | SEC |
| Aug 12, 20244:58 PM ET | Jan MakelaOfficer | 33.1K | $2.75M | Aug 12, 2024 | UBS Financial Services Inc | SEC |
| Aug 7, 20245:30 PM ET | Thomas WestrickOfficer | 2.75K | $222.1K | Aug 7, 2024 | UBS Financial Services Inc | SEC |
| May 28, 20244:58 PM ET | Taha Kass-HoutOfficer | 3.30K | $259.7K | May 28, 2024 | UBS Financial Services Inc | SEC |
| May 17, 20245:05 PM ET | Betty LarsonOfficer | 13.6K | $1.11M | May 17, 2024 | UBS Financial Services Inc | SEC |
| May 13, 20244:48 PM ET | Jan MakelaOfficer | 87.2K | $7.11M | May 13, 2024 | UBS Financial Services Inc | SEC |
| Jul 31, 20235:45 PM ET | Kevin O'NeillOfficer | 15.6K | $1.21M | Jul 31, 2023 | UBS Financial Services Inc | SEC |
| Jun 8, 20232:48 PM ET | Roland RottOfficer | 2.47K | $191.3K | Jun 8, 2023 | UBS Financial Services Inc | SEC |